Usefulness of a selective neutrophil elastase inhibitor and a recombinant human soluble thrombomodulin in patients with ARDS and DIC

S. Miyoshi, R. Ito, A. Kato, H. Katayama, K. Irifune, H. Hamada, K. Dote, M. Aibiki, T. Okura, J. Higaki (Toon, Hiroshima, Japan)

Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations
Session: Acute respiratory failure, ARDS and severe COPD exacerbations
Session type: Thematic Poster Session
Number: 2421
Disease area: Respiratory critical care

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Miyoshi, R. Ito, A. Kato, H. Katayama, K. Irifune, H. Hamada, K. Dote, M. Aibiki, T. Okura, J. Higaki (Toon, Hiroshima, Japan). Usefulness of a selective neutrophil elastase inhibitor and a recombinant human soluble thrombomodulin in patients with ARDS and DIC. Eur Respir J 2013; 42: Suppl. 57, 2421

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic value of urokinase plasminogen activator receptor (uPAR) and neutrophil CD64 expression in acute respiratory distress syndrome patients
Source: Annual Congress 2013 –Acute respiratory failure, ARDS and severe COPD exacerbations
Year: 2013


Del-1 reduces endotoxin-induced polymorphonuclear leukocytes adhension and mortality
Source: Annual Congress 2013 –Experimental models in critical care
Year: 2013


The potential efficacy of noninvasive ventilation with administration of a neutrophil elastase inhibitor for acute respiratory distress syndrome
Source: International Congress 2014 – ARDS, skeletal muscles, physiology and weaning
Year: 2014

Usefulness of selective neutrophil elastase inhibitor, sivelestat, in ALI patients with SIRS
Source: Annual Congress 2012 - How to use technology to provide better critical care
Year: 2012



Human neutrophil elastase in acute bronchiolitis
Source: Eur Respir J 2004; 24: Suppl. 48, 24s
Year: 2004

Alpha1-antitrypsin (α1-AT) and secretory leukocyte protease inhibitor (SLPI) in acute lung injury/acute respiratory distress syndrome (ALI/ARDS) in critically ill infants
Source: Annual Congress 2008 - Respiratory disorders in paediatric intensive care unit
Year: 2008


Prophylactic neutrophil elastase inhibitor (sivelestat) attenuates subsequent ventilator-induced lung injury
Source: International Congress 2014 – ARDS, skeletal muscles, physiology and weaning
Year: 2014

Neutralizing the complement component C5a protects against lung injury and extrapulmonary organ injury in pneumococcal pneumonia induced sepsis
Source: International Congress 2014 – Critical illness and therapeutic interventions
Year: 2014

Heparin effect in pulmonary cell populations in an in-vitro model of acute lung injury
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016


Dexamethasone inhibits secretory and cytosolic phospholipases A2 in alveolar macrophages in acute lung injury
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013

Oral inhalation of AP301 peptide activates pulmonary oedema clearance: Initial results from a phase IIa clinical trial in mechanically ventilated ICU patients
Source: International Congress 2014 – Critical illness and therapeutic interventions
Year: 2014


Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation
Source: Eur Respir J 2007; 30: 423-428
Year: 2007



Acute increase in KL-6/MUC1 mucin as a potential trigger of disseminated intravascular coagulation in acute respiratory distress syndrome
Source: Annual Congress 2006 - Acute respiratory distress syndrome (ARDS): from pathophysiology to clinical management
Year: 2006


Effects of nebulized heparin on pulmonary inflammation in a rat model of acute lung injury
Source: International Congress 2015 – Acute critical care: novelties in critical care
Year: 2015

Salmeterol prevents pneumonia and reduces biomarkers of inflammation/epithelial damage but not acute lung injury following oesophagectomy-the results of BALTI-prevention trial
Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights
Year: 2013

Heparin effect in alveolar cells and macrophages in an acute lung injury model
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015

LATE-BREAKING ABSTRACT: The metalloproteinase ADAM8 promotes acute and chronic lung inflammation
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015

A mouse model of acute lung injury implicates phospholipase Cε in neutrophilic inflammation through CXC chemokine production
Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair
Year: 2016


Methotrexate reduces acute lung injury in a murine model of sepsis
Source: International Congress 2016 – Infections, sepsis, and pulmonary embolism
Year: 2016


Effect of antithrombin in an in vitro model of acute respiratory distress syndrome
Source: International Congress 2016 – Sepsis and ARDS: looking forward
Year: 2016